Summary
Definition
History and exam
Diagnostic tests
Treatment algorithm
Contributors
Authors
Elisabeth Adderson, MD
Associate Member
St. Jude Children's Research Hospital
Associate Professor of Pediatrics
University of Tennessee Health Sciences Center
Memphis
TN
Disclosures
EA declares that she has no competing interests.
Peer reviewers
Elizabeth Barnett, MD, FAAP
Director of International Clinical Maxwell Finland Laboratory for Infectious Diseases
Boston Medical Center
Associate Professor of Pediatrics
Boston University School of Medicine
Boston
MA
Disclosures
EB has received research grant support from Sandipasteen and Intercell and received an honorarium to attend a meeting sponsored by Novartis. She receives royalties from the sale of a book she edited.
Suzanne M. Garland, MBBS, MD, FRCPAm FAChSHM, FRANZCOG ad eundem
Director of Microbiological Research
Head of Clinical Microbiology and Infectious Diseases
Royal Women's Hospital
Senior Consultant of Microbiology
Royal Children's Hospital
Professor
Faculty of Medicine, Dentistry and Health
Department of Obstetrics and Gynaecology
University of Melbourne
Melbourne
Australia
Disclosures
SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck and GSK. SMG has received funding through her institution to conduct HPV vaccine studies for MSD and GSK.
Robert S. Duszak, OD, FAAO
Co-Director of Residency Program and Consulting Staff
Philadelphia Veterans Affairs Medical Center
Consulting Staff
Nemours Health Clinic & Mayfair Eye Associates
Adjunct Clinical Faculty
Pennsylvania College of Optometry
Salus University
Philadelphia
PA
Divulgaciones
RSD declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Centers for Disease Control and Prevention. Rubella (German measles, three-day measles). Dec 2020 [internet publication].Texto completo
Centers for Disease Control and Prevention. CDC Yellow Book 2024. Section 5: travel-associated infections and diseases - rubella. May 2023 [internet publication].Texto completo
McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Texto completo Resumen
Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2025. Nov 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States, 2025. Nov 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Rubella/German measles: 2013 case definition. 2013 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible aquí.
Use of this content is subject to our disclaimer